The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review

The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review

No abstract, as A letter to the Editor.

Bibliographic Details
Main Authors:	Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim
Format:	Article
Language:	English
Published:	PAGEPress Publications 2020-10-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	COVID-19, Multiple myeloma (MM), ARDS (acute respiratory distress syndrome), Interlukin6 (IL-6), Tocilizumab.
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/4386

Similar Items

Why tocilizumab could be an effective treatment for severe COVID-19?
by: Binqing Fu, et al.
Published: (2020-04-01)

Anti-IL6R role in treatment of COVID-19-related ARDS
by: Franco Maria Buonaguro, et al.
Published: (2020-04-01)

Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
by: Corrado Pelaia, et al.
Published: (2021-03-01)

Tocilizumab as a Treatment for ‘Cytokine Storm Syndrome’ in COVID-19: A Case Report
by: Ari Fahrial Syam, et al.
Published: (2021-07-01)

Potential role of tocilizumab in severe gastrointestinal barrier damage after CAR T-cell therapy
by: David Beauvais, et al.
Published: (2021-04-01)

Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis
by: Sakkas LI
Published: (2016-08-01)

The Effects of Topical Ketamine Gel on Saliva and Serum Level of Interlukin-6 in Patients with Recurrent Aphthous Ulceration
by: Ahmed A. Mohammad, et al.
Published: (2015-04-01)

Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India
by: Yojana Gokhale, et al.
Published: (2021-03-01)

Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
by: Danielle Harmer, et al.
Published: (2019-01-01)

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
by: Etienne Dufranc, et al.
Published: (2020-04-01)

Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma
by: Sydney Grob, et al.
Published: (2019-08-01)

Prognostic value of IL6 in young adults presenting with acute coronary syndrome
by: Ahmed Mowafy, et al.
Published: (2015-06-01)

TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling
by: Gali Epstein Shochet, et al.
Published: (2020-02-01)

The Two-Faced Cytokine IL-6 in Host Defense and Diseases
by: Masashi Narazaki, et al.
Published: (2018-11-01)

Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men
by: Beckey Trinh, et al.
Published: (2021-09-01)

IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis
by: O Mehtap, et al.
Published: (2014-01-01)

IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome
by: Peter Riddell, et al.
Published: (2021-01-01)

Effects of IL-6 Signaling Pathway Inhibition on Weight and BMI: A Systematic Review and Meta-Analysis
by: Olivia Patsalos, et al.
Published: (2020-08-01)

Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial
by: Tomohiro Koga, et al.
Published: (2018-12-01)

Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
by: Yasuaki Tomioka, et al.
Published: (2021-09-01)

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
by: Qiu Wei, et al.
Published: (2021-05-01)

The COVID-19 Cytokine Storm; What We Know So Far
by: Dina Ragab, et al.
Published: (2020-06-01)

The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review
by: Avi Gurion Kaye, et al.
Published: (2020-11-01)

Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
by: Yi Miao, et al.
Published: (2020-06-01)

Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19
by: Shoji Hashimoto, et al.
Published: (2021-09-01)

Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC
by: Rachel E. Piddock, et al.
Published: (2018-05-01)

Renal cell carcinoma and plasma cell myeloma: Unique association and clinical implications
by: Somanath Padhi, et al.
Published: (2014-01-01)

Maternal Serum and Cervicovaginal IL-6 in Patients with Symptoms of Preterm Labor
by: Parisa Yavari Kia, et al.
Published: (2016-09-01)

Immunoglobulin free light chains and interleukin-6 levels in prediction of kidney injury in patients with multiple myeloma
by: Izeta Aganovic-Musinovic, et al.
Published: (2019-03-01)

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
by: Francesco Perrone, et al.
Published: (2020-10-01)

Anti-IL6 Autoantibodies in an Infant With CRP-Less Septic Shock
by: Marketa Bloomfield, et al.
Published: (2019-11-01)

Synergistic efficacy of tramadol and meloxicam on alleviation of pain and selected immunological variables after sciatic nerve ligation in rats
by: Marwa Abass, et al.
Published: (2014-06-01)

Effect of olive oil on IL-6, TNF-α and cortisol hormone levels in active girls after one session of an exhaustive exercise: a brief report
by: Bakhtyar Tartibian, et al.
Published: (2013-09-01)

Effect of 8 weeks resistance training on plasma levels of nerve growth factor and interlukin-6 in female patients with multiple sclerosis
by: Mehrzad Moghadasi, et al.
Published: (2015-07-01)

Galectin-3 as a Biomarker for Stratifying Abdominal Aortic Aneurysm Size in a Taiwanese Population
by: Hsin-Ying Lu, et al.
Published: (2021-05-01)

Role of plasma TNF-α and IL-6 levels in prediction of acute respiratory distress syndrome based on their synchronous detection
by: GAN Zhixin, et al.
Published: (2020-03-01)

Effects of temperature and anticoagulant on the in vitro quantitation of Leukocyre Expressed Mac-1 and Post-traumatic assay to predict the development of ARDS
by: Pitt, Tracy Shawn
Published: (2001)

Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
by: Birgitte Tholin, et al.
Published: (2020-10-01)

The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome
by: Masatoshi Matsunami, et al.
Published: (2018-10-01)

Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation
by: Daniel Meley, et al.
Published: (2017-08-01)

Cannot write session to /tmp/vufind_sessions/sess_li5h8aal7515udo8l54jd9cfjc